88
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer

, , , , , , , , , , , , & show all
Pages 8329-8339 | Published online: 03 Nov 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
  • Siegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.2125425559415
  • Kelland L, Clarke J, McKeage M. Advances in platinum complex cancer chemotherapy. Platinum Metals Rev. 1992;36:178–184.
  • Akaza H, Saijo N, Aiba K, et al. Platinum compounds in cancer therapy–past, present, and future. Gan ToKagaku Ryoho. 2001;28(5):625–635.
  • Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. CurrOpin Cell Biol. 2009;21(4):575–581. doi:10.1016/j.ceb.2009.03.007
  • Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920. doi:10.1016/j.jprot.2010.06.00620601276
  • Gross JC, Chaudhary V, Bartscherer K, et al. Active Wnt proteins are secreted on exosomes. Nat Cell Biol. 2012;14(10):1036–1045. doi:10.1038/ncb257422983114
  • Sato-Kuwabara Y, Melo SA, Soares FA, et al. The fusion of two worlds: non-coding RNAs and extracellular vesicles–diagnostic and therapeutic implications (Review). Int J Oncol. 2015;46(1):17–27. doi:10.3892/ijo.2014.271225338714
  • Ogata-Kawata H, Izumiya M, Kuriokaet D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014;9(4):e92921. doi:10.1371/journal.pone.009292124705249
  • Huang XY, Yuan TZ, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319. doi:10.1186/14712164-14-31923663360
  • Song SJ, Ito K, Ala U, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to Promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 2013;13(1):87–101. doi:10.1016/j.stem.2013.06.00323827711
  • Garofalo M, Croce CM. Role of microRNAs in maintaining cancer stem cells. Adv DrugDeliv Rev. 2015;81:53–61. doi:10.1016/j.addr.2014.11.014
  • Tanno T, Zhang P, Lazarski CA, et al. An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth. Blood Adv. 2017;1(15):1107–1119. doi:10.1182/bloodadvances.201700470529296753
  • Kloten V, Neumann MHD, Di Pasquale F, et al. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. Clin Chem. 2019;65(9):1132–1140. doi:10.1373/clinchem.2019.303271.31235535
  • Hassan MN, Waller EK. Treating chemotherapy-induced thrombocytopenia: is it time for oncologists to use thrombopoietin agonists? Oncology. 2015;29(4):295–296.25952493
  • Barreto JN, McCullough KB, Ice LL, et al. Antineoplastic agents and then associated myelosuppressive effects: a review. J Pharm Pract. 2014;27(5):440–446. doi:10.1177/089719001454610825147158
  • Hao S, Chen C, Cheng T. Cell cycle regulation of hematopoietic stem or progenitor cells. Int J Hematol. 2016;103(5):487–497. doi:10.1007/s12185-016-1984-427084253
  • He SH, Roberts PJ, Sorrentino JA, et al. Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion. Sci Transl Med. 2017;9(387):eaal3986. doi:10.1126/scitranslmed.aal398628446688
  • Johnson SM, Torrice CD, Bell JF, et al. Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest. 2010;120(7):2528–2536. doi:10.1172/JCI4140220577054
  • Chou J, Quigley DA, Robinsonet TM, et al. Transcription-associated cyclin-dependent kinases as targets and biomarkers for cancer therapy. Cancer Discov. 2020;10(3):351–370. doi:10.1158/2159-8290.CD-19-052832071145
  • Li C, Qin Y, Yang TO, et al. miR-122-5p Mediates Fluoride-Induced Osteoblast Activation by Targeting CDK4. Biol Trace Elem Res. 2021;199(4):1215–1227. doi:10.1007/s12011-020-02239-z32572801
  • Xu Z, Liu GC, Zhang M, et al. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA. Cell Physiol Biochem. 2018;48(6):2596–2606. doi:10.1159/00049270230121648
  • Venkatadri R, Muni T, Iyer V, et al. Role of apoptosis‐related miRNAs in resveratrol induced breast cancer cell death. Cell Death Dis. 2016;7(2):e2104. doi:10.1038/cddis.2016.626890143
  • Ergun S, Ulasli M, Igci YZ, et al. The association of the expression of miR‐122‐5p and its target ADAM10 with human breast cancer. Mol Biol Rep. 2015;42:497‐505. doi:10.1007/s11033-014-3793-2